Nagpal et al. reported that neratinib promotes ferroptosis and inhibited brain metastasis in HER-2-positive breast cancer, but the underlying mechanism of how neratinib is inducing ferroptosis is obscure [103]. This evidence concerns the gene ERBB2 and breast cancer.